Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Enterprise Value: 2010-2024

Historic Enterprise Value for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to -$13.4 million.

  • OptimizeRx's Enterprise Value fell 2104.06% to -$19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year decrease of 2104.06%. This contributed to the annual value of -$13.4 million for FY2024, which is 340.75% up from last year.
  • Per OptimizeRx's latest filing, its Enterprise Value stood at -$13.4 million for FY2024, which was up 340.75% from -$13.9 million recorded in FY2023.
  • OptimizeRx's Enterprise Value's 5-year high stood at -$10.5 million during FY2020, with a 5-year trough of -$84.7 million in FY2021.
  • Moreover, its 5-year median value for Enterprise Value was -$13.9 million (2023), whereas its average is -$39.3 million.
  • As far as peak fluctuations go, OptimizeRx's Enterprise Value crashed by 70520.66% in 2021, and later skyrocketed by 8131.69% in 2023.
  • OptimizeRx's Enterprise Value (Annual) stood at -$10.5 million in 2020, then crashed by 705.21% to -$84.7 million in 2021, then rose by 12.45% to -$74.1 million in 2022, then surged by 81.32% to -$13.9 million in 2023, then increased by 3.41% to -$13.4 million in 2024.
  • Its Enterprise Value was -$13.4 million in FY2024, compared to -$13.9 million in FY2023 and -$74.1 million in FY2022.